0001144204-17-011044.txt : 20170224
0001144204-17-011044.hdr.sgml : 20170224
20170224173801
ACCESSION NUMBER: 0001144204-17-011044
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170224
FILED AS OF DATE: 20170224
DATE AS OF CHANGE: 20170224
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DERMA SCIENCES, INC.
CENTRAL INDEX KEY: 0000892160
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 232328753
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 214 CARNEGIE CENTER, SUITE 300
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 6095144744
MAIL ADDRESS:
STREET 1: 214 CARNEGIE CENTER, SUITE 300
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: DERMA SCIENCES INC
DATE OF NAME CHANGE: 19940513
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NAVARRO SAMUEL E
CENTRAL INDEX KEY: 0001269368
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13070
FILM NUMBER: 17638776
MAIL ADDRESS:
STREET 1: C/O STRATA SKIN SCIENCES, INC.
STREET 2: 100 LAKESIDE DRIVE, SUITE 100
CITY: HORSHAM
STATE: PA
ZIP: 19044
4
1
v460296_form4.xml
FORM 4
X0306
4
2017-02-24
1
0000892160
DERMA SCIENCES, INC.
DSCI
0001269368
NAVARRO SAMUEL E
C/O CARDICA, INC.
900 SAGINAW DRIVE
REDWOOD CITY
CA
94063
1
0
0
0
Common Stock
2017-02-24
4
D
0
37500
D
0
D
Common Stock
2017-02-24
4
D
0
25000
A
25000
D
Restricted Stock Units
2017-02-24
4
D
0
25000
0
D
Common Stock
25000
0
D
Pursuant to the terms of the Agreement and Plan of Merger, dated January 10, 2017, by and among the Issuer, Integra Derma, Inc. and Integra LifeSciences Holdings Corporation (the "Merger Agreement"), as of the Effective Time (as defined in the Merger Agreement), the shares of the Issuer's common stock were converted into the right to receive $7.00 per share to the reporting person in cash.
Represents shares of the Issuer's common stock received upon the vesting of 25,000 restricted stock units, as described herein.
Upon the Effective Time, and in connection with a tender offer pursuant to which Integra Derma, Inc. offered to purchase all of the Issuer's common stock for $7.00 per share, the restricted stock units were converted into the right to receive an amount in cash equal to $7.00 with respect to each share of common stock underlying such award, payable without any interest thereon and subject to any required tax withholdings.
The restricted stock units were originally granted in consideration of the reporting person's services to the Issuer and without payment of consideration.
/s/ Samuel E. Navarro
2017-02-24